These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38853380)

  • 1. Bayesian transition models for ordinal longitudinal outcomes.
    Rohde MD; French B; Stewart TG; Harrell FE
    Stat Med; 2024 Aug; 43(18):3539-3561. PubMed ID: 38853380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating whether the proportional odds models to analyse ordinal outcomes in COVID-19 clinical trials is providing clinically interpretable treatment effects: A systematic review.
    Uddin M; Bashir NZ; Kahan BC
    Clin Trials; 2024 Jun; 21(3):363-370. PubMed ID: 37982237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial.
    Kaizer AM; Shapiro NI; Wild J; Brown SM; Cwik BJ; Hart KW; Jones AE; Pulia MS; Self WH; Smith C; Smith SA; Ng PC; Thompson BT; Rice TW; Lindsell CJ; Ginde AA
    Int J Infect Dis; 2023 Mar; 128():223-229. PubMed ID: 36581186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian multivariate hierarchical model for developing a treatment benefit index using mixed types of outcomes.
    Wu D; Goldfeld KS; Petkova E; Park HG
    BMC Med Res Methodol; 2024 Sep; 24(1):218. PubMed ID: 39333874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian design of clinical trials using joint models for longitudinal and time-to-event data.
    Xu J; Psioda MA; Ibrahim JG
    Biostatistics; 2022 Apr; 23(2):591-608. PubMed ID: 33155038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing toxicities in a clinical trial: Bayesian inference for ordinal data nested within categories.
    Leon-Novelo LG; Zhou X; Bekele BN; Müller P
    Biometrics; 2010 Sep; 66(3):966-74. PubMed ID: 19930188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical analysis of the longitudinal fundamental movement skills data in the REACT project using the multilevel ordinal logistic model.
    Hedeker D; Pereira S; Garbeloto F; Barreira TV; Garganta R; Farias C; Tani G; Chaput JP; Stodden DF; Maia J; Katzmarzyk PT
    Am J Hum Biol; 2024 Jul; 36(7):e24015. PubMed ID: 37982324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many leveled ordinal models for frequency of alcohol and drug use.
    Chambers MS; Drovandi C
    Am J Drug Alcohol Abuse; 2023 Sep; 49(5):566-575. PubMed ID: 37358833
    [No Abstract]   [Full Text] [Related]  

  • 10. Bayesian inference for joint modelling of longitudinal continuous, binary and ordinal events.
    Li Q; Pan J; Belcher J
    Stat Methods Med Res; 2016 Dec; 25(6):2521-2540. PubMed ID: 25411326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.
    Griffiths G; Fitzgerald R; Jaki T; Corkhill A; Marwood E; Reynolds H; Stanton L; Ewings S; Condie S; Wrixon E; Norton A; Radford M; Yeats S; Robertson J; Darby-Dowman R; Walker L; Khoo S;
    Trials; 2020 Jun; 21(1):544. PubMed ID: 32560744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting growth curve models in the Bayesian framework.
    Oravecz Z; Muth C
    Psychon Bull Rev; 2018 Feb; 25(1):235-255. PubMed ID: 28493149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian analysis of nonlinear mixed-effects mixture models for longitudinal data with heterogeneity and skewness.
    Lu X; Huang Y
    Stat Med; 2014 Jul; 33(16):2830-49. PubMed ID: 24623529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian workflow for disease transmission modeling in Stan.
    Grinsztajn L; Semenova E; Margossian CC; Riou J
    Stat Med; 2021 Nov; 40(27):6209-6234. PubMed ID: 34494686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian joint modeling of ordinal longitudinal measurements and competing risks survival data for analysing Tehran Lipid and Glucose Study.
    Baghfalaki T; Kalantari S; Ganjali M; Hadaegh F; Pahlavanzadeh B
    J Biopharm Stat; 2020 Jul; 30(4):689-703. PubMed ID: 32129702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian compositional models for ordinal response.
    Zhang L; Zhang X; Leach JM; Rahman AF; Yi N
    Stat Methods Med Res; 2024 Jun; 33(6):1043-1054. PubMed ID: 38654396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian framework for modeling COVID-19 case numbers through longitudinal monitoring of SARS-CoV-2 RNA in wastewater.
    Dai X; Acosta N; Lu X; Hubert CRJ; Lee J; Frankowski K; Bautista MA; Waddell BJ; Du K; McCalder J; Meddings J; Ruecker N; Williamson T; Southern DA; Hollman J; Achari G; Ryan MC; Hrudey SE; Lee BE; Pang X; Clark RG; Parkins MD; Chekouo T
    Stat Med; 2024 Mar; 43(6):1153-1169. PubMed ID: 38221776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.
    Troxel AB; Petkova E; Goldfeld K; Liu M; Tarpey T; Wu Y; Wu D; Agarwal A; Avendaño-Solá C; Bainbridge E; Bar KJ; Devos T; Duarte RF; Gharbharan A; Hsue PY; Kumar G; Luetkemeyer AF; Meyfroidt G; Nicola AM; Mukherjee A; Ortigoza MB; Pirofski LA; Rijnders BJA; Rokx C; Sancho-Lopez A; Shaw P; Tebas P; Yoon HA; Grudzen C; Hochman J; Antman EM
    JAMA Netw Open; 2022 Jan; 5(1):e2147331. PubMed ID: 35076699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Exploratory Diagnostic Model for Ordinal Responses with Binary Attributes: Identifiability and Estimation.
    Culpepper SA
    Psychometrika; 2019 Dec; 84(4):921-940. PubMed ID: 31432312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible Bayesian additive joint models with an application to type 1 diabetes research.
    Köhler M; Umlauf N; Beyerlein A; Winkler C; Ziegler AG; Greven S
    Biom J; 2017 Nov; 59(6):1144-1165. PubMed ID: 28796339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.